Clinical Trials Arena on MSN
ImmunityBio’s glioblastoma regimen boosts survival in mid-stage study
As of 22 January, 19 of the 23 patients who have received treatment are still alive, with the longest evaluable survival ...
The Times of Israel on MSN
Fruit fly study, almost wrecked by Iran, claims to uncover key to radiation-defying cells
Rescuing larvae from missile-damaged lab, Weizmann team finds cells that not only beat back death, but also multiply and spur ...
Prescribing information and clinical guidelines showed gaps in TB screening protocols for many recently approved targeted ...
Key market opportunities include leveraging molecular switches for targeted drug delivery systems and therapies in oncology, autoimmune, inflammatory, and neurological disorders. Innovations in ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果